ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 132 filers reported holding ANAPTYSBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,454,526 | -0.2% | 80,987 | +13.1% | 0.00% | – |
| Q2 2023 | $1,456,712 | -32.1% | 71,618 | -27.4% | 0.00% | – |
| Q1 2023 | $2,146,190 | -27.8% | 98,630 | +2.8% | 0.00% | – |
| Q4 2022 | $2,972,436 | +8.3% | 95,916 | -10.8% | 0.00% | – |
| Q3 2022 | $2,744,000 | -7.8% | 107,568 | -26.7% | 0.00% | – |
| Q2 2022 | $2,976,000 | +14.6% | 146,655 | +39.7% | 0.00% | – |
| Q1 2022 | $2,597,000 | +2.8% | 104,991 | +44.4% | 0.00% | – |
| Q4 2021 | $2,527,000 | +29.5% | 72,727 | +1.1% | 0.00% | – |
| Q3 2021 | $1,951,000 | -53.4% | 71,946 | -55.5% | 0.00% | -100.0% |
| Q2 2021 | $4,191,000 | +21.9% | 161,675 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $3,438,000 | +642.5% | 159,539 | +640.6% | 0.00% | – |
| Q4 2020 | $463,000 | +324.8% | 21,543 | +189.2% | 0.00% | – |
| Q3 2020 | $109,000 | -74.9% | 7,450 | -61.6% | 0.00% | – |
| Q2 2020 | $434,000 | -93.9% | 19,396 | -96.2% | 0.00% | -100.0% |
| Q1 2020 | $7,123,000 | -58.2% | 504,094 | -51.9% | 0.00% | -50.0% |
| Q4 2019 | $17,034,000 | +137.5% | 1,048,265 | +411.5% | 0.00% | +100.0% |
| Q3 2019 | $7,171,000 | +970.3% | 204,959 | +1627.7% | 0.00% | – |
| Q2 2019 | $670,000 | -17.2% | 11,863 | +7.1% | 0.00% | – |
| Q1 2019 | $809,000 | -91.8% | 11,079 | -92.9% | 0.00% | -100.0% |
| Q4 2018 | $9,921,000 | +193.6% | 155,532 | +359.3% | 0.00% | +200.0% |
| Q3 2018 | $3,379,000 | +15.8% | 33,863 | -17.6% | 0.00% | 0.0% |
| Q2 2018 | $2,917,000 | -25.4% | 41,072 | +9.4% | 0.00% | 0.0% |
| Q1 2018 | $3,908,000 | -88.0% | 37,549 | -88.4% | 0.00% | -88.9% |
| Q4 2017 | $32,573,000 | +5865.8% | 323,394 | +1971.4% | 0.01% | – |
| Q3 2017 | $546,000 | +351.2% | 15,612 | +208.3% | 0.00% | – |
| Q2 2017 | $121,000 | -80.5% | 5,064 | -77.3% | 0.00% | – |
| Q1 2017 | $620,000 | – | 22,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
| EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
| GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
| Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
| Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
| Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
| Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
| Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
| TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
| Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |